Search form

 

Press Releases


Please select a year to review:
           

2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004

2005

December 15, 2005
Axcan Exceeds Patient Randomization Target Necessary for Completion of North American ITAX 'Itopride' Phase III Trial - Company is on Track for NDA Filing in the Summer of 2006

November 10, 2005
Axcan reports fourth quarter and year-end 2005 financial results - Company generates record revenues of $67.0 million for the quarter

November 09, 2005
Axcan Pharma to present at Credit Suisse First Boston's Healthcare Conference

November 03, 2005
Axcan Announces Conference Call and Web Cast for Fourth Quarter and Fiscal 2005 Results

October 28, 2005
Axcan Pharma to Present at CIBC's 16th Annual Healthcare Conference

September 22, 2005
Axcan Pharma to present at the UBS Global Life Sciences Conference

September 13, 2005
Photofrin PDT reduces esophageal cancer occurrence in patients with Barrett's High Grade Dysplasia - Results of a 5-year follow-up study

August 11, 2005
Axcan announces third quarter 2005 results

August 09, 2005
Axcan Pharma to present at the Orion Securities 10th annual healthcare conference

August 02, 2005
Axcan announces conference call and webcast for third quarter of fiscal 2005 results

June 09, 2005
More than 1000 patients enrolled in Axcan's ITAX Phase III functional dyspepsia studies

June 08, 2005
Axcan Pharma to present at the Merrill Lynch Canada 12th Annual Growth Stock Conference in Toronto

May 30, 2005
Media Advisory - In cooperation with McGill University and the University of Toronto - International specialists meet to discuss Photodynamic Therapy in the treatment and prevention of cancer

May 26, 2005
Axcan Pharma to present at the 9th Annual Friedman Billings Ramsey Growth Investor Conference in New York City

May 19, 2005
Frank Verwiel Named Axcan President and Chief Executive Officer - Léon Gosselin to Continue as Chairman of the Board

May 18, 2005
Axcan Pharma to Present at UBS Global Specialty Pharmaceuticals Conference in New York City

May 04, 2005
Axcan reports second quarter 2005 results

April 27, 2005
Axcan announces Conference Call and Web cast for Second Quarter of Fiscal 2005 Results

April 20, 2005
Axcan Pharma to Present at Scotia Capital Pharmaceutical and Biotechnology Conference in Toronto

February 28, 2005
Axcan Launches CANASA 1000 mg in the U.S.

February 18, 2005
Axcan Pharma to host Analyst/Investor Luncheons in Toronto and New-York

February 17, 2005
Annual General Meeting of Shareholders - Axcan Prepares for a New Era of Growth - Advances ITAX Development Program and Launch Strategy

February 16, 2005
Axcan Pharma Inc. to hold annual shareholder's meeting February 17, 2005

February 14, 2005
Axcan Reports First Quarter 2005 Results

February 10, 2005
Axcan Pharma to Hold Annual General Meeting of Shareholders February 17, 2005

February 07, 2005
Axcan Announces Conference Call and Web Cast for First Quarter of Fiscal 2005 Results

February 03, 2005
Axcan Pharma to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference in New York

January 06, 2005
Axcan Pharma to Present at JP Morgan Healthcare Conference 2005 in San Francisco